Evidence map›Paper›PMID 34355330›Full record

ArticleJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract2022

Early Versus Late Recurrence in Rectal Cancer: Does Timing Matter?

Marina Affi Koprowski, Thomas L Sutton, Nima Nabavizadeh, Charles Thomas, Emerson Chen, Adel Kardosh, Charles Lopez, Skye C Mayo, Kim Lu, Daniel Herzig and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Marina Affi KoprowskiDepartment of Surgery, Oregon Health and Science University (OHSU), 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA.
Thomas L SuttonDepartment of Surgery, Oregon Health and Science University (OHSU), 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA.
Nima NabavizadehDepartment of Radiation Medicine, OHSU, 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA.
Charles ThomasDepartment of Radiation Medicine, OHSU, 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA.
Emerson ChenDivision of Hematology & Oncology, Department of Medicine, OHSU, 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA.
Adel KardoshDivision of Hematology & Oncology, Department of Medicine, OHSU, 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA.
Charles LopezDivision of Hematology & Oncology, Department of Medicine, OHSU, 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA.
Skye C MayoDivision of Surgical Oncology, Department of Surgery, OHSU, 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA.
Kim LuDivision of General and Gastrointestinal Surgery, Department of Surgery, OHSU, 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA.
Daniel HerzigDivision of General and Gastrointestinal Surgery, Department of Surgery, OHSU, 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA.
V Liana TsikitisDivision of General and Gastrointestinal Surgery, Department of Surgery, OHSU, 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA. tsikitis@ohsu.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe definition of early recurrence (ER) in rectal cancer is unclear, and the association of ER with post-recurrence survival (PRS) is poorly described. We therefore sought to identify if time to recurrence (TTR) is associated with PRS.

methodsWe reviewed all curative-intent resections of nonmetastatic rectal cancer from 2003 to 2018 in our institutional registry within an NCI-Designated Comprehensive Cancer Center. Clinicopathologic data at diagnosis and first recurrence were collected and analyzed. ER was pre-specified at < 24 months and late recurrence (LR) at ≥ 24 months. PRS was evaluated by the Kaplan-Meier method and Cox proportional hazards modeling.

resultsAt a median follow-up of 53 months, 61 out of 548 (11.1%) patients undergoing resection experienced recurrence. Median TTR was 14 months (IQR 10-18) with 45 of 61 patients (74%) classified as ER. There were no significant baseline differences between patients with ER and LR. Most recurrences were isolated to the liver (26%) or lung (31%), and 16% were locoregional. ER was not associated with worse PRS compared to LR (P > 0.99). On multivariable analysis, detection of recurrence via workup for symptoms, CEA > 10 ng/mL at recurrence, and site of recurrence were independently associated with PRS.

conclusionER is not associated with PRS in patients with resected rectal cancer. Symptomatic recurrences and those accompanied by CEA elevations are associated with worse PRS, while metastatic disease confined to the liver or lung is associated with improved PRS. Attention should be directed away from TTR and instead toward determining therapy for patients with treatable oligometastatic disease.

Indexed as

Neoplasm Recurrence, LocalRectal NeoplasmsHumansPrognosisRetrospective StudiesRisk FactorsRectal cancerRecurrenceSurvival

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.